News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
674,645 Results
Type
Article (52251)
Company Profile (231)
Press Release (622147)
Multimedia
Podcasts (138)
Webinars (17)
Section
Business (181048)
Career Advice (1225)
Deals (31332)
Drug Delivery (133)
Drug Development (74244)
Employer Resources (108)
FDA (16166)
Job Trends (14334)
News (309401)
Policy (30898)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (2700)
Academic (1)
Accelerated approval (47)
Adcomms (26)
Allergies (184)
Alliances (44431)
ALS (203)
Alzheimer's disease (1732)
Antibody-drug conjugate (ADC) (474)
Approvals (16629)
Artificial intelligence (703)
Autoimmune disease (323)
Automation (56)
Bankruptcy (274)
Best Places to Work (11485)
BIOSECURE Act (23)
Biosimilars (206)
Biotechnology (158)
Bladder cancer (200)
Brain cancer (81)
Breast cancer (778)
Cancer (5969)
Cardiovascular disease (483)
Career advice (1073)
Career pathing (27)
CAR-T (341)
CDC (71)
Celiac Disease (3)
Cell therapy (928)
Cervical cancer (50)
Clinical research (65247)
Collaboration (2123)
Company closure (3)
Compensation (1246)
Complete response letters (67)
COVID-19 (2724)
CRISPR (113)
C-suite (1224)
Cystic fibrosis (157)
Data (8119)
Decentralized trials (3)
Denatured (47)
Depression (165)
Dermatology (85)
Diabetes (595)
Diagnostics (6578)
Digital health (59)
Diversity (13)
Diversity, equity & inclusion (29)
Drug discovery (325)
Drug pricing (219)
Drug shortages (35)
Duchenne muscular dystrophy (271)
Earnings (74654)
Editorial (65)
Employer branding (16)
Employer resources (102)
Events (114329)
Executive appointments (1156)
FDA (20036)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (17)
Frontotemporal dementia (34)
Funding (1707)
Gene editing (241)
Generative AI (55)
Gene therapy (723)
GLP-1 (1071)
Government (4982)
Grass and pollen (7)
Guidances (407)
Healthcare (19637)
HIV (86)
Huntington's disease (44)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (98)
Immunology and inflammation (270)
Immuno-oncology (96)
Indications (194)
Infectious disease (3074)
Inflammatory bowel disease (223)
Inflation Reduction Act (13)
Influenza (135)
Intellectual property (266)
Interviews (178)
IPO (14648)
IRA (54)
Job creations (3257)
Job search strategy (954)
JPM (53)
Kidney cancer (21)
Labor market (76)
Layoffs (485)
Leadership (24)
Legal (6648)
Liver cancer (102)
Longevity (26)
Lung cancer (804)
Lymphoma (430)
Machine learning (60)
Management (33)
Manufacturing (1018)
MASH (198)
Medical device (14639)
Medtech (14775)
Mergers & acquisitions (17881)
Metabolic disorders (1519)
mRNA (209)
Multiple sclerosis (179)
NASH (19)
Neurodegenerative disease (392)
Neuropsychiatric disorders (100)
Neuroscience (3219)
Neurotech (1)
NextGen: Class of 2026 (6470)
Non-profit (4593)
Now hiring (53)
Obesity (696)
Opinion (248)
Ovarian cancer (230)
Pain (266)
Pancreatic cancer (307)
Parkinson's disease (359)
Partnered (30)
Patents (545)
Patient recruitment (709)
Peanut (65)
People (59552)
Pharmaceutical (46)
Pharmacy benefit managers (33)
Phase 1 (20170)
Phase 2 (28641)
Phase 3 (21840)
Pipeline (8912)
Policy (340)
Postmarket research (2412)
Preclinical (8272)
Press Release (63)
Prostate cancer (313)
Psychedelics (46)
Radiopharmaceuticals (342)
Rare diseases (1082)
Real estate (5240)
Recruiting (47)
Regulatory (24791)
Reports (30)
Research institute (2516)
Resumes & cover letters (150)
Rett syndrome (39)
RNA editing (24)
RSV (87)
Schizophrenia (179)
Series A (295)
Series B (210)
Service/supplier (4)
Sickle cell disease (116)
Special edition (24)
Spinal muscular atrophy (176)
Sponsored (37)
Startups (3475)
State (1)
Stomach cancer (18)
Supply chain (125)
Tariffs (83)
The Weekly (88)
Vaccines (1134)
Venture capital (97)
Weight loss (451)
Women's health (125)
Worklife (13)
Date
Today (149)
Last 7 days (638)
Last 30 days (3401)
Last 365 days (29864)
2026 (13432)
2025 (29811)
2024 (34408)
2023 (39196)
2022 (50073)
2021 (54234)
2020 (52375)
2019 (45917)
2018 (34856)
2017 (31164)
2016 (30284)
2015 (35422)
2014 (27072)
2013 (22443)
2012 (23953)
2011 (24532)
2010 (23312)
Location
Africa (750)
Alabama (86)
Alaska (7)
Arizona (298)
Arkansas (16)
Asia (42873)
Australia (6850)
California (13242)
Canada (3544)
China (1474)
Colorado (579)
Connecticut (597)
Delaware (404)
Europe (89611)
Florida (1912)
Georgia (435)
Hawaii (3)
Idaho (55)
Illinois (1110)
India (95)
Indiana (629)
Iowa (22)
Japan (546)
Kansas (115)
Kentucky (52)
Louisiana (45)
Maine (54)
Maryland (1587)
Massachusetts (9618)
Michigan (293)
Minnesota (725)
Mississippi (7)
Missouri (153)
Montana (37)
Nebraska (28)
Nevada (140)
New Hampshire (91)
New Jersey (3557)
New Mexico (32)
New York (3409)
North Carolina (1788)
North Dakota (10)
Northern California (6765)
Ohio (385)
Oklahoma (25)
Oregon (45)
Pennsylvania (2585)
Puerto Rico (29)
Rhode Island (47)
South America (1008)
South Carolina (88)
South Dakota (2)
Southern California (5136)
Tennessee (202)
Texas (2054)
United States (46703)
Utah (367)
Vermont (1)
Virginia (314)
Washington D.C. (80)
Washington State (1049)
West Virginia (4)
Wisconsin (129)
Wyoming (2)
674,645 Results for "hutchison china meditech chi med".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Prof. Dr. med. Jürgen Braun Appointed as New Member of the Scientific Advisory Board
· Prof. Dr. med. Jürgen Braun joins the Scientific Advisory Board of MetrioPharm AG. · With more than 800 peer-reviewed publications and various prestigious awards, Prof. Braun is internationally recognized as a leading expert in the field of modern clinical and academic rheumatology.
May 26, 2026
·
1 min read
Funding
RA Capital Looks to China for Next Startup To Put on SPAC Track to Nasdaq
While RA Capital Management has yet to commit to a merger plan, it noted that its new blank-check company, Research Alliance III, could target companies abroad, including those from China.
March 25, 2026
·
2 min read
·
Tristan Manalac
China
Lilly Pumps $3B Into China To Boost Supply of Weight Loss Pill
Orforglipron, Eli Lilly’s oral obesity drug, is under FDA review with a decision expected in April. The pharma has also filed for marketing authorization for the pill in China.
March 11, 2026
·
2 min read
·
Tristan Manalac
Weight loss
Regeneron’s Weight Loss Partner Hansoh Delivers Much-Needed Phase 3 Win in China
Hansoh’s olatorepatide achieved 19% weight loss at 48 weeks in a Phase 3 trial in China, handing partner Regeneron a glimmer of hope for a pipeline in desperate need of reinvigoration.
March 9, 2026
·
2 min read
·
Annalee Armstrong
China
Clinical Trials Are Increasingly Going Global—With China a Main Beneficiary
AstraZeneca’s $15 billion pledge to its China operations highlights the country’s advantages. But other regions are also hoping to host more clinical studies.
February 2, 2026
·
8 min read
·
Annalee Armstrong
Pain
AbbVie enters world of pain in up to $715M deal with China’s Haisco
The licensing deal marks AbbVie’s first foray into new pain medicines, a space where Vertex currently enjoys a lead thanks to the NaV1.8 inhibitor Journavx.
April 13, 2026
·
1 min read
·
Annalee Armstrong
Obesity
Kailera, Hengrui Push Oral GLP-1/GIP Pill to Phase 3 After Clearing Mid-Stage China Study
Kailera will launch a global Phase 2 study of ribupatide this year, while Hengrui will push the asset into Phase 3 in China.
February 10, 2026
·
1 min read
·
Tristan Manalac
Mergers & acquisitions
Chiesi snaps up KalVista for $1.9B, betting big on rare disease med Ekterly
Chiesi Group is taking KalVista Pharmaceuticals under its wing, paying $1.9 billion for the biotech’s oral therapy Ekterly to treat severe swelling episodes caused by the rare genetic disorder hereditary angioedema.
April 29, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
Vor Bio Announces Publication of Interim Analysis of TELIGAN, a China Phase 3 Trial of Telitacicept in IgA Nephropathy, in The New England Journal of Medicine
May 14, 2026
·
6 min read
Press Releases
Dizal’s ZEGFROVY® (Sunvozertinib) New Drug Application Accepted and Granted Priority Review by China National Medical Products Administration for First-Line Treatment of EGFR Exon 20 Insertion-Mutated Non-Small Cell Lung Cancer
May 27, 2026
·
5 min read
1 of 67,465
Next
